Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

NCT00749476 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

BIOLOGICAL: Factor IX recovery

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer